Table 2

Associations of tumor characteristics with the TLI status.


All patients
Patients with TLI-low
Patients with TLI-high
p-value


n
%
n
%
n
%


Histologic type






0.556
Invasive ductal
182
67.9
72
39.6
110
60.4

Invasive lobular
18
6.7
9
50.0
9
50.0

Mixed ductal&lobular
50
18.7
18
36.0
32
64.0

Other
18
6.7
5
27.8
13
72.2

Multifocality + Multicentricity






0.456
Yes
34
12.7
11
32.4
23
67.6

No
234
87.3
93
39.7
141
60.3

Nuclear Grade






0.008
1+2
177
66
79
44.6
98
55.4

3
91
34
25
27.5
66
72.5

Histologic Grade






0.999
1+2
136
50.7
53
39.0
83
61.0

3
132
49.3
51
38.6
81
61.4

Lymphovascular invasion






0.753
Yes
206
76.9
81
39.3
125
60.7

No
62
23.1
23
37.1
39
62.9

Estrogen receptor (ER) status






0.124
ER-positive
173
64.6
73
42.2
100
57.8

ER-negative
95
35.4
31
32.6
64
67.4

Progesteron receptor (PR) status






0.134
PR-positive
69
25.7
32
46.4
37
53.6

PR-negative
199
74.3
72
36.2
127
63.8


Sen-Oran et al. World Journal of Surgical Oncology 2007 5:93   doi:10.1186/1477-7819-5-93